Search for: "Ely Lilly"
Results 1261 - 1280
of 2,157
Sort by Relevance
|
Sort by Date
18 May 2011, 12:33 am
Highlights this week included: US: FTC alleges companies were asleep at the wheel when they failed to report settlement agreements on Ambien CR; Commission uses the opportunity to provide industry guidance – and a warning (FDA Law Blog) (GenericsWeb) Gemzar (Gemcitabine) – US: Certiorari denied in Eli Lilly v. [read post]
16 May 2011, 9:46 pm
Noonan -- The Supreme Court refused today to grant certiorari in Eli Lilly & Co. v. [read post]
12 May 2011, 2:25 pm
Prosecutors have been citing as a benchmark a $1.4 billion settlement that Eli Lilly & Co. reached in 2009 to resolve a probe into alleged improper marketing of its antipsychotic drug Zyprexa, according to one of the people. [read post]
11 May 2011, 4:54 am
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty:… [read post]
10 May 2011, 4:43 pm
Circuit)Petition for certiorariBrief in opposition for the International Trade Commission Brief in opposition for US Phillips Coroporation Petitioners' reply Title: Eli Lilly and Company v. [read post]
6 May 2011, 8:37 am
Merck, Medtronic, Zimmer and several other companies are reportedly under investigation and Eli Lilly just disclosed that it is in negotiations with the SEC to resolve their own investigation. [read post]
5 May 2011, 1:57 am
Last week, Eli Lilly. disclosed that it is in “advanced discussions” to settle bribery related allegations. [read post]
4 May 2011, 10:00 am
., and Indianapolis-based Eli Lilly Co. [read post]
4 May 2011, 8:32 am
To counter these arguments, proponents of the whistleblower program cite to other successful programs with robust monetary rewards like that under the False Claims Act, which helped facilitate large settlements with pharmaceutical giants Pfizer and Eli Lilly for corporate misconduct. [read post]
4 May 2011, 4:13 am
(Patent Law Practice Center) US: Abraxis files for patent term adjustment calculation review for patent entitled ‘Compositions and methods of delivery of pharmacological agents’ (Patent Docs) US: ITC: Target date set in Certain Vaginal Ring Birth Control Devices (ITC 337 Law Blog) US: Court confused by patent reexamination results: Cellectricon v Fluxion Biosciences (Patents Post-Grant) Products AndroGel (Testosterone) – US: Abbott sues Teva in attempt to block US sales of generic… [read post]
3 May 2011, 9:02 am
The case was Eli Lilly & Company v. [read post]
2 May 2011, 3:14 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
2 May 2011, 1:12 pm
Byetta is marketed by Amylin Pharmaceuticals and Eli Lilly. [read post]
2 May 2011, 4:30 am
The jury found that the company had sent 7,604 "Dear Doctor" letters and made a total of 27,542 sales calls in which its sales representatives claimed Risperdal was safer than competing antipsychotic drugs such as Eli Lilly's Zyprexa and AstraZeneca's Seroquel. [read post]
30 Apr 2011, 5:22 am
” Eli Lilly & Co. v. [read post]
30 Apr 2011, 5:00 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
29 Apr 2011, 1:03 pm
" Eli Lilly & Co. v. [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
28 Apr 2011, 1:40 pm
The court order in SD Ind requires that the remaining defendants not make generic Cymbalta during the patent term and that they tell the FDA that they are no longer seeking approval for a generic duloxetine product during the patent term. [read post]
19 Apr 2011, 5:15 pm
It was a boon to the bottom line of its manufacturer, Eli Lilly, but it also became a cautionary tale for the drug industry—of pharmaceutical success inspiring suspicion, controversy and backlash. [read post]
